Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease. - Wikidata - wikimedia - TriplyDB

Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease.

Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease.

http://www.wikidata.org/entity/Q34104188

about

Plaque and tangle imaging and cognition in normal aging and Alzheimer's disease Characteristics of Tau and Its Ligands in PET Imaging Clinicopathologic assessment and imaging of tauopathies in neurodegenerative dementias Quantum dots and prion proteins: is this a new challenge for neurodegenerative diseases imaging?Brain PET in the diagnosis of Alzheimer's disease Towards a Pharmacophore for Amyloid PET amyloid-beta imaging in preclinical Alzheimer's disease Cerebral [18 F]T807/AV1451 retention pattern in clinically probable CTE resembles pathognomonic distribution of CTE tauopathy.What have novel imaging techniques revealed about metabolism in the aging brain?A review of neuroimaging findings in repetitive brain trauma.Human gene therapy and imaging in neurological diseases.Near-infrared fluorescent probes for imaging of amyloid plaques in Alzheimer׳s disease Imaging noradrenergic influence on amyloid pathology in mouse models of Alzheimer's disease Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies.Quantitative analysis of [18F]FDDNP PET using subcortical white matter as reference region In vivo human amyloid imaging.Differential FDDNP PET patterns in nondemented middle-aged and older adults Neuroprotective properties of chitosan and its derivatives.Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer's disease pathologies.Optimization of automated radiosynthesis of [18F]AV-45: a new PET imaging agent for Alzheimer's disease.On the origin of the stronger binding of PIB over thioflavin T to protofibrils of the Alzheimer amyloid-β peptide: a molecular dynamics study.Assessment of dementia risk in aging adults using both FDG-PET and FDDNP-PET imaging.Tau PET imaging: present and future directions.Binding of nonsteroidal anti-inflammatory drugs to Abeta fibril [F-18]FDDNP microPET imaging correlates with brain Aβ burden in a transgenic rat model of Alzheimer disease: effects of aging, in vivo blockade, and anti-Aβ antibody treatment.FDG- and amyloid-PET in Alzheimer's disease: is the whole greater than the sum of the parts?Visualization of regional tau deposits using (3)H-THK5117 in Alzheimer brain tissue.Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis Synthesis and evaluation of novel chalcone derivatives with (99m)Tc/Re complexes as potential probes for detection of β-amyloid plaques.Rhodanine and thiohydantoin derivatives for detecting tau pathology in Alzheimer's brains.BODIPY-based molecular probe for imaging of cerebral β-amyloid plaques.Quick assembly of 1,4-diphenyltriazoles as probes targeting beta-amyloid aggregates in Alzheimer's disease.Quantitative multimodal multiparametric imaging in Alzheimer's disease.Neuroimaging findings in human prion disease.PET Radioligands for Imaging of Tau Pathology: Current Status.Dicyanovinylnaphthalenes for neuroimaging of amyloids and relationships of electronic structures and geometries to binding affinities Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-beta.Strategies for molecular imaging dementia and neurodegenerative diseases.Postmortem 3-D brain hemisphere cortical tau and amyloid-β pathology mapping and quantification as a validation method of neuropathology imaging.F-18 stilbenes as PET imaging agents for detecting beta-amyloid plaques in the brain.

P2860

Q24629601-7224D40B-38F5-489B-85F9-89A176A13C03 Q26769952-AF181D4C-A020-4BD8-8B9F-16E8F8A0B3E6 Q27003078-75902ADE-FDB3-4717-ACEC-F10BCF48B44E Q27008857-A904CFC0-BA91-4639-908E-A095A5A743CB Q27011549-4A629364-D0A1-4D15-B6A1-2E28519D4AA1 Q27670496-6BF8675A-9F63-458D-A68D-2B3D6965B624 Q30040695-80EACC1C-6110-4F4F-9FD1-BAC0069B1B1C Q30275833-EBDB87A7-BF5B-4851-A2AF-EDAAB9EE66F0 Q30850844-CD126483-AE9E-48DE-A150-C647A7DF0A44 Q30938680-BBB72F25-FB42-4EE0-9046-DE760399E0A6 Q31023442-EA6B236C-B2F0-43DB-A8FF-99BB456485EF Q31025427-F16DC8D1-42B6-499B-9590-A48E9149F1D6 Q31143998-3540FF40-9497-4CFF-B19F-3F19AD92AE3E Q33590723-DB8804D4-35C8-4B06-903A-1DE6D144883C Q33654396-59630F74-BC7C-435F-9D0F-15075A562744 Q33790277-D0FA6ED0-4718-4EA6-B814-06A41A6F1E0E Q33899796-86E9364E-0DEC-45A2-87DF-5F28F64CCEC4 Q34061851-F61A8476-6CDB-467E-AFFF-7948994C90AA Q34102715-1B479A97-D491-46BF-9B7D-C31735EF4CB7 Q34356658-9CF9F13A-2F4A-46B8-8887-FA506F679560 Q34594635-34EAED60-0EA3-42BD-975E-34D17B53995E Q34678734-890C14C4-5973-41AA-8661-131264CE0FC7 Q34680852-A2C3665F-DF92-489D-BF8E-819DD6952565 Q34680971-C50ADFD2-5F1C-4617-A27B-26A0A0695AA5 Q35131160-5ACA8448-DDB2-42CA-BD76-71E38CB221C0 Q35792038-409631B1-E040-43BD-8FC6-0AC56E01646B Q35810005-62538C23-8B91-4192-B262-374976B2D8B2 Q35896890-66416067-10A4-4496-A03F-94F6E7D728B5 Q36012379-696D49C8-7760-4AC7-A5E4-32E40298DFFB Q36015406-97C7918A-59CA-4EDB-AD20-2A13D8F147A8 Q36015598-173080FE-25B3-4328-8CD6-C4170EA4BD46 Q36028775-46073A9C-492F-4211-9DF4-A61CBA481387 Q36164757-47E78D60-FC04-41E2-8CE2-A5045BBB9989 Q36226989-BCDC1E89-6543-44DE-A63C-8CE53A37F3A5 Q36241261-FF26F41F-9174-42A6-8515-9FCED74E70A0 Q36339800-8D2D6FAB-99F7-4802-A2F0-1C4DA327E3DB Q36526176-5DCD86B0-A1A6-47A4-811C-4A41743ADFC9 Q36853915-6830D095-62C9-46DA-BAEE-BB2D30F066A1 Q36944895-C97544BE-337C-460F-9739-10A87BFB736E Q36996052-25BB47C1-FD49-4D6C-B094-DC900550E654

P2860

Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease.

http://www.wikidata.org/entity/Q34104188

description

2001 nî lūn-bûn

@nan

2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Binding characteristics of rad ...... laques in Alzheimer's disease.

@ast

Binding characteristics of rad ...... laques in Alzheimer's disease.

@en

Binding characteristics of rad ...... laques in Alzheimer's disease.

@nl

type

label

Binding characteristics of rad ...... laques in Alzheimer's disease.

@ast

Binding characteristics of rad ...... laques in Alzheimer's disease.

@en

Binding characteristics of rad ...... laques in Alzheimer's disease.

@nl

prefLabel

Binding characteristics of rad ...... laques in Alzheimer's disease.

@ast

Binding characteristics of rad ...... laques in Alzheimer's disease.

@en

Binding characteristics of rad ...... laques in Alzheimer's disease.

@nl

P1433

Q34104188-5066EEC0-62B3-4931-AFA0-C5172F8B2A60

P1476

Q34104188-7EFF3399-9050-427B-BD4F-FAF5AC9C1654

P2093

Q34104188-0F46BA8D-CF10-46B8-AE09-98D4E21FEB25

Q34104188-387E1513-B11D-429B-81C3-9047C2AC8C84

Q34104188-3EF0855E-A454-4F31-9CBD-B177541E6062

Q34104188-630F4B8C-BF22-475D-A195-265B1B8D66FA

Q34104188-6CE444C5-E9B2-4C3F-BDC7-EFE141227EC7

Q34104188-76C8B98C-8141-4A33-B502-5DF8ABDF4F91

Q34104188-9DBBB187-F1E8-45D7-9F9B-4423BB4E53C3

Q34104188-B9AF6F64-1EED-49FE-A742-6EFCA48CC44A

Q34104188-C0EDD47D-3E16-490A-88F8-F388F33A9A1A

Q34104188-DD3F1ADB-E96F-45F5-80A9-9CA2C0CA42FC

P304

Q34104188-06BEBC04-F87C-4E76-A923-84DF28241E2E

P31

Q34104188-C3C8EC4C-2F56-4E11-9351-900C65E2CA6D

P407

Q34104188-3CAAFFA7-D783-4A0E-A11A-F2D3DC927747

P433

Q34104188-A5F05100-4D1D-4481-AB96-065CAA37BC0A

P478

Q34104188-B7F835F8-04EE-4213-8ACE-71EF9EF16A9D

P577

Q34104188-0D370085-306B-4458-AF5E-6C6F13763DD7

P698

Q34104188-7DB44DEF-3E18-4759-A746-D8AB5E763BAB

P921

Q34104188-902EF873-E24D-490A-B343-7A71AEAEE508

P1433

Journal of Neuroscience

P1476

Binding characteristics of rad ...... laques in Alzheimer's disease.

@en

P2093

Agdeppa ED

http://www.w3.org/2001/XMLSchema#string

Barrio JR

http://www.w3.org/2001/XMLSchema#string

Cole GM

http://www.w3.org/2001/XMLSchema#string

Flores-Torres S

http://www.w3.org/2001/XMLSchema#string

Huang SC

http://www.w3.org/2001/XMLSchema#string

Kepe V

http://www.w3.org/2001/XMLSchema#string

Liu J

http://www.w3.org/2001/XMLSchema#string

Petric A

http://www.w3.org/2001/XMLSchema#string

Satyamurthy N

http://www.w3.org/2001/XMLSchema#string

Small GW

http://www.w3.org/2001/XMLSchema#string

P304

RC189

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2001-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11734604

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease